We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+23.45%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$208M
AUM Growth
+$24.2M
Cap. Flow
+$7.64M
Cap. Flow %
3.66%
Top 10 Hldgs %
36.52%
Holding
103
New
33
Increased
10
Reduced
10
Closed
44

Top Buys

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$6.88M
2
GILD icon
Gilead Sciences
GILD
+$6.72M
3
PBYI icon
Puma Biotechnology
PBYI
+$5.55M
4
CPHD
Cepheid Inc
CPHD
+$5.06M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$4.64M

Top Sells

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$5.48M
2
TRNX
TORNIER N V SHARES (NLD)
TRNX
+$4.78M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.49M
4
AGN
Allergan Inc
AGN
+$4.46M
5
HCA icon
HCA Healthcare
HCA
+$4.23M

Sector Composition

Rank Sector Weight
1 Healthcare 74.72%
2 Miscellaneous 23.48%
3 Technology 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLXP
26
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$3.45M 1.65%
+30,000
New +$3.63M
AMAG
27
DELISTED
AMAG Pharmaceuticals
AMAG
$3.41M 1.64%
+80,000
New +$2.89M
ADXS
28
DELISTED
Advaxis Inc
ADXS
$3.39M 1.63%
+28,207
New +$1.58M
UHS icon
29
Universal Health Services
UHS
$10B
$3.34M 1.6%
+30,000
New +$3.15M
SYK icon
30
Stryker
SYK
$116B
$3.3M 1.58%
+35,000
New +$3.1M
IONS icon
31
PUT
Ionis Pharmaceuticals
IONS
$9.65B
$3.09M 1.48%
+50,000
New +$2.47M
ISEE
32
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.92M 1.4%
+65,000
New +$2.73M
QDEL icon
33
QuidelOrtho
QDEL
$958M
$2.89M 1.39%
100,000
– –
BHC icon
34
Bausch Health
BHC
$2.45B
$2.86M 1.37%
20,000
-5,000
-20% -$673K
TXMD icon
35
TherapeuticsMD
TXMD
$25.6M
$2.83M 1.36%
12,736
-2,264
-15% -$467K
BLUE
36
DELISTED
bluebird bio
BLUE
$2.75M 1.32%
2,316
-386
-14% -$258K
FOLD
37
DELISTED
Amicus Therapeutics
FOLD
$2.5M 1.2%
+300,000
New +$2.06M
ARAY icon
38
Accuray
ARAY
$31.9M
$2.27M 1.09%
+300,000
New +$2.12M
DBVT
39
DBV Technologies
DBVT
$847M
$2.17M 1.04%
+8,000
New +$2.06M
ISRG icon
40
Intuitive Surgical
ISRG
$130B
$2.12M 1.02%
36,000
-40,500
-53% -$2.26M
BDSI
41
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2.1M 1.01%
+175,000
New +$2.66M
ARIA
42
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$2.06M 0.99%
300,000
-400,000
-57% -$2.5M
ATRC icon
43
AtriCure
ATRC
$2.62B
$2M 0.96%
100,000
-150,000
-60% -$2.57M
ACHN
44
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$1.84M 0.88%
150,000
– –
IMGN
45
CALL
DELISTED
Immunogen Inc
IMGN
$1.83M 0.88%
+300,000
New +$2.74M
BLCM
46
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.73M 0.83%
+7,500
New +$1.61M
RPTP
47
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$1.58M 0.76%
+150,000
New +$1.47M
MMSI icon
48
Merit Medical Systems
MMSI
$5.35B
$1.3M 0.62%
+75,000
New +$1.11M
TNDM icon
49
Tandem Diabetes Care
TNDM
$1.38B
$1.27M 0.61%
10,000
-3,150
-24% -$437K
NSTG
50
DELISTED
NanoString Technologies, Inc.
NSTG
$1.25M 0.6%
90,000
– –
1
2
3 4 5

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Ghost Tree Capital held 103 positions worth $208M, up 13% from $184M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ghost Tree Capital deployed $7.64M of net new capital in Q4 2014, opening 33 new positions and adding to 10 existing holdings. Its largest new stake was Wright Medical Group Inc: 235,000 shares worth $6.31M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 67% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was AtriCure, an estimated $2.57M trimmed.

  • Ghost Tree Capital's largest Q4 2014 buy was Wright Medical Group Inc: 235,000 shares worth $6.31M.
  • Ghost Tree Capital added most to Puma Biotechnology in Q4 2014, an estimated $5.55M increase.
  • Ghost Tree Capital's biggest Q4 2014 reduction was AtriCure, cutting an estimated $2.57M.
  • Ghost Tree Capital fully exited Community Health Systems in Q4 2014, selling an estimated $5.48M.
  • Ghost Tree Capital's ten largest holdings make up 37% of its $208M portfolio in Q4 2014.
  • Ghost Tree Capital opened 33 new positions and closed 44 in Q4 2014.
  • Ghost Tree Capital's portfolio value rose 13% quarter-over-quarter to $208M.

Based on Ghost Tree Capital's 13F filing for Q4 2014, filed 17 Feb 2015.